Hero banner

World Cancer Day 2026 Webinar Series | November—Lung Cancer Awareness Month

26 November 2026
17:00 (CET)
Online

Welcome from
the chair

MDPI World Cancer Day 2026 Webinar Series  | November—Lung Cancer Awareness Month 

To commemorate World Cancer Day 2026, MDPI is pleased to introduce the “World Cancer Day 2026 Webinar Series”. Reflecting the global theme “United by Unique”, this series highlights how every story, discovery, and voice contributes to strengthening the global fight against cancer.

In our November session, we welcome leading voices in lung cancer research to share impactful insights, raise awareness, and highlight recent advances in prevention, diagnosis, and treatment.

Through this series, we aim to empower the global community with knowledge, inspire collaboration, and support ongoing efforts to address cancer worldwide. Together, we honour every patient’s journey, recognize every researcher’s contribution, and reinforce the power of collective action in the fight against cancer.

Date: 26 November 2026
Time: 17:00 (CET) | 11:00 (EST) 
Webinar ID: 843 5135 2572 
Webinar Secretariat: webinar@mdpi.com



Welcome Message

MDPI World Cancer Day 2026 Webinar Series  | November—Lung Cancer Awareness Month 

To commemorate World Cancer Day 2026, MDPI is pleased to introduce the “World Cancer Day 2026 Webinar Series”. Reflecting the global theme “United by Unique”, this series highlights how every story, discovery, and voice contributes to strengthening the global fight against cancer.

In our November session, we welcome leading voices in lung cancer research to share impactful insights, raise awareness, and highlight recent advances in prevention, diagnosis, and treatment.

Through this series, we aim to empower the global community with knowledge, inspire collaboration, and support ongoing efforts to address cancer worldwide. Together, we honour every patient’s journey, recognize every researcher’s contribution, and reinforce the power of collective action in the fight against cancer.

Date: 26 November 2026
Time: 17:00 (CET) | 11:00 (EST) 
Webinar ID: 843 5135 2572 
Webinar Secretariat: webinar@mdpi.com

Meet Our Speakers

Explore more speakers
Dr. Luca Bertolaccini

Department of Oncology and Hematology-Oncology, University of Milan, Italy;Department of Thoracic Surgery, IEO, European Institute of Oncology IRCCS, Italy;Luca Bertolaccini is an Assistant Professor at the University of Milan and a Deputy Director of the Division of Thoracic Surgery at the IEO, European Institute of Oncology IRCCS in Milan, Italy. His clinical and research interests include minimally invasive thoracic surgery, lung cancer outcomes, clinical registries, and the application of artificial intelligence to thoracic oncology. His research examines how routinely collected clinical data can support surgical decision-making, quality assessment, and the evaluation of cancer care. He is particularly interested in the methodological requirements for developing and validating predictive models, including data quality, reproducibility, and clinical applicability. He contributes to international collaborative research and guideline development through European and international thoracic oncology societies. His current work includes studies of machine learning in lung cancer oncology and analyses of thoracic surgical databases.

Dr. Federico Pio Fabrizio

Faculty of Medicine and Surgery, University of Enna “Kore”, Enna, Italy;Federico Pio Fabrizio is an Associate Professor of Molecular Biology at the Faculty of Medicine and Surgery, University of Enna “Kore”, Italy. He holds a PhD in Experimental and Regenerative Medicine from the University of Foggia and a Specialization in Clinical Pathology and Clinical Biochemistry from the University Campus Bio-Medico of Rome. He previously worked as a Postdoctoral Fellow at Casa Sollievo della Sofferenza in San Giovanni Rotondo and subsequently held a fixed-term Assistant Professor position at the European Institute of Oncology (IEO) in Milan. His research focuses on cancer epigenetics and translational oncology, particularly in NSCLC. His main interests include epigenetic regulation, DNA methylation biomarkers, liquid biopsy, circulating tumour DNA, tumour heterogeneity and plasticity, and the molecular mechanisms underlying therapeutic response and resistance. His research aims to clarify the role of epigenetic alterations in cancer development and progression, with particular emphasis on their potential as biomarkers and therapeutic targets in precision oncology.

Dr. Kelsie Thu

St. Michael's Hospital, Unity Health Toronto, Canada ;Laboratory Medicine and Pathobiology, University of Toronto, Canada;Kelsie Thu is a Scientist at the Keenan Research Centre for Biomedical Science at St. Michael’s Hospital of Unity Health Toronto, and an Assistant Professor in the Laboratory Medicine and Pathobiology Department at the University of Toronto. She holds a Canada Research Chair in Lung Cancer Therapy Response. Her research program focuses on identifying molecular mechanisms governing lung tumour growth and progression using clinical and functional genomic approaches in cell and animal models. She seeks to discover novel therapeutic targets to inform the development of new and improved treatments to overcome drug resistance and enhance the efficacy of standard of care therapies in lung cancer patients. The Thu Lab is currently developing alternative modes of delivering CD47-targeted immunotherapy to enhance its efficacy, characterizing mechanisms that enable tolerance and resistance to EGFR tyrosine kinase inhibitors, and investigating therapeutic vulnerabilities associated with centrosome amplification and chromosomal instability in lung cancer.

Program

Speaker

Time in CET

Time in EST

MDPI Host
Cancers Introduction

17:00 - 17:05 

11:00 - 11:05 

Dr. Luca Bertolaccini
Artificial Intelligence in Thoracic Oncology Databases: From Data Quality to Clinical Insight

17:05 - 17:25 

11:05 - 11:25 

Dr. Federico Pio Fabrizio
DNA Methylation-Based Biomarkers in Lung Cancer: Novel Signatures and Clinical Perspectives

17:25 - 17:45 

11:25 - 11:45 

Dr. Kelsie Thu
Targeting Kinesins to Exploit Chromosomal Instability in Lung Cancer

17:45 - 18:05 

11:45 - 12:05 

Q&A

18:05 - 18:25

12:05 - 12:25 

Host
Closing of Webinar

18:25 - 18:30 

12:25 - 12:30

Registration Instructions

This is a FREE webinar. After registering, you will receive a confirmation email containing information on how to join the webinar.  Registrations with academic institutional email addresses will be prioritized.

Certificates of attendance will be delivered to those who attend the live webinar.


Can’t attend? Register anyway and we’ll let you know when the recording is available to watch.

Register for free here!

Sponsors and Partners

Organizers


MDPICancersCurrent Oncology

Powered by Sciforum
Disclaimer
Terms and ConditionsPrivacy PolicyAccessibility